180 related articles for article (PubMed ID: 26562548)
1. Controlled synthesis of N,N,N-trimethyl chitosan for modulated bioadhesion and nasal membrane permeability.
Pardeshi CV; Belgamwar VS
Int J Biol Macromol; 2016 Jan; 82():933-44. PubMed ID: 26562548
[TBL] [Abstract][Full Text] [Related]
2. New nasal nanocomplex self-assembled from charged biomacromolecules: N,N,N-Trimethyl chitosan and dextran sulfate.
Kulkarni AD; Vanjari YH; Sancheti KH; Patel HM; Belgamwar VS; Surana SJ; Pardeshi CV
Int J Biol Macromol; 2016 Jul; 88():476-90. PubMed ID: 27017981
[TBL] [Abstract][Full Text] [Related]
3. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.
Yin L; Ding J; He C; Cui L; Tang C; Yin C
Biomaterials; 2009 Oct; 30(29):5691-700. PubMed ID: 19615735
[TBL] [Abstract][Full Text] [Related]
4. Physicochemical properties and biocompatibility of N-trimethyl chitosan: effect of quaternization and dimethylation.
Jintapattanakit A; Mao S; Kissel T; Junyaprasert VB
Eur J Pharm Biopharm; 2008 Oct; 70(2):563-71. PubMed ID: 18602467
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B surface antigen nanoparticles coated with chitosan and trimethyl chitosan: Impact of formulation on physicochemical and immunological characteristics.
Tafaghodi M; Saluja V; Kersten GF; Kraan H; Slütter B; Amorij JP; Jiskoot W
Vaccine; 2012 Aug; 30(36):5341-8. PubMed ID: 22749834
[TBL] [Abstract][Full Text] [Related]
6. Optimized synthesis of O-carboxymethyl-N,N,N-trimethyl chitosan.
Patrulea V; Applegate LA; Ostafe V; Jordan O; Borchard G
Carbohydr Polym; 2015 May; 122():46-52. PubMed ID: 25817641
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of neuropeptide loaded trimethyl chitosan nanoparticles for nose to brain delivery.
Kumar M; Pandey RS; Patra KC; Jain SK; Soni ML; Dangi JS; Madan J
Int J Biol Macromol; 2013 Oct; 61():189-95. PubMed ID: 23831532
[TBL] [Abstract][Full Text] [Related]
8. Histological evaluation of buccal penetration enhancement properties of chitosan and trimethyl chitosan.
Sandri G; Poggi P; Bonferoni MC; Rossi S; Ferrari F; Caramella C
J Pharm Pharmacol; 2006 Oct; 58(10):1327-36. PubMed ID: 17034655
[TBL] [Abstract][Full Text] [Related]
9. N,N,N-Trimethyl chitosan: An advanced polymer with myriad of opportunities in nanomedicine.
Kulkarni AD; Patel HM; Surana SJ; Vanjari YH; Belgamwar VS; Pardeshi CV
Carbohydr Polym; 2017 Feb; 157():875-902. PubMed ID: 27988003
[TBL] [Abstract][Full Text] [Related]
10. Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: In vitro and in vivo evaluation.
Paliwal R; Paliwal SR; Agrawal GP; Vyas SP
Int J Pharm; 2012 Jan; 422(1-2):179-84. PubMed ID: 22079712
[TBL] [Abstract][Full Text] [Related]
11. Efficient mucus permeation and tight junction opening by dissociable "mucus-inert" agent coated trimethyl chitosan nanoparticles for oral insulin delivery.
Liu M; Zhang J; Zhu X; Shan W; Li L; Zhong J; Zhang Z; Huang Y
J Control Release; 2016 Jan; 222():67-77. PubMed ID: 26686663
[TBL] [Abstract][Full Text] [Related]
12. Nasal and rectal delivery of insulin with chitosan and N-trimethyl chitosan chloride.
du Plessis LH; Kotzé AF; Junginger HE
Drug Deliv; 2010 Aug; 17(6):399-407. PubMed ID: 20429846
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system.
Amidi M; Romeijn SG; Borchard G; Junginger HE; Hennink WE; Jiskoot W
J Control Release; 2006 Mar; 111(1-2):107-16. PubMed ID: 16380189
[TBL] [Abstract][Full Text] [Related]
14. Mannose-anchored N,N,N-trimethyl chitosan nanoparticles for pulmonary administration of etofylline.
Pardeshi CV; Agnihotri VV; Patil KY; Pardeshi SR; Surana SJ
Int J Biol Macromol; 2020 Dec; 165(Pt A):445-459. PubMed ID: 32987078
[TBL] [Abstract][Full Text] [Related]
15. Effect of chitosan structure properties and molecular weight on the intranasal absorption of tetramethylpyrazine phosphate in rats.
Mei D; Mao S; Sun W; Wang Y; Kissel T
Eur J Pharm Biopharm; 2008 Nov; 70(3):874-81. PubMed ID: 18656537
[TBL] [Abstract][Full Text] [Related]
16. Positively Charged Chitosan and N-Trimethyl Chitosan Inhibit Aβ40 Fibrillogenesis.
Liu H; Ojha B; Morris C; Jiang M; Wojcikiewicz EP; Rao PP; Du D
Biomacromolecules; 2015 Aug; 16(8):2363-73. PubMed ID: 26125953
[TBL] [Abstract][Full Text] [Related]
17. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
[TBL] [Abstract][Full Text] [Related]
18. Insulin-loaded nanoparticles based on N-trimethyl chitosan: in vitro (Caco-2 model) and ex vivo (excised rat jejunum, duodenum, and ileum) evaluation of penetration enhancement properties.
Sandri G; Bonferoni MC; Rossi S; Ferrari F; Boselli C; Caramella C
AAPS PharmSciTech; 2010 Mar; 11(1):362-71. PubMed ID: 20232266
[TBL] [Abstract][Full Text] [Related]
19. In vitro and ex vivo intestinal tissue models to measure mucoadhesion of poly (methacrylate) and N-trimethylated chitosan polymers.
Keely S; Rullay A; Wilson C; Carmichael A; Carrington S; Corfield A; Haddleton DM; Brayden DJ
Pharm Res; 2005 Jan; 22(1):38-49. PubMed ID: 15771228
[TBL] [Abstract][Full Text] [Related]
20. TMC-MCC (N-trimethyl chitosan-mono-N-carboxymethyl chitosan) nanocomplexes for mucosal delivery of vaccines.
Sayin B; Somavarapu S; Li XW; Sesardic D; Senel S; Alpar OH
Eur J Pharm Sci; 2009 Nov; 38(4):362-9. PubMed ID: 19733658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
